“Malaria vaccines are moving from the laboratory into the real world,” Dr. Carlos C. (Kent) Campbell, director of PATH’s Malaria Control Program, writes in an editorial published today in The New England Journal of Medicine. The “remarkable progress in malaria control” over the last five years has made malaria eradication a global goal, he writes, and the next five years will be critical in sustaining that progress and finding lifesaving solutions for the millions of people at risk of infection.
The editorial accompanies two articles published in the journal announcing new discoveries about malaria. In one article, scientists describe how live mosquitoes may offer a solution for delivering immunity against malaria parasites through their bites. The other article notes that resistance to malaria drugs is spreading, especially in Asia. These results add to scientists’ understanding of malaria and offer new insights into finding critical interventions for malaria protection.
For more information
- Dr. Campbell’s editorial in The New England Journal of Medicine.
- The current issue of The New England Journal of Medicine, including articles about resistance to malaria drugs and the potential for protection through mosquito bites.
- PATH’s work in finding solutions to malaria.
Posted July 30, 2009.